Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity

Journal of Cell Biology

Volumn 131, Issue 6 II, 1995, Pages 1849-1855

  Driessens, Mariëtte H E ^a   Stroeken, Peter J M ^a   Rodriguez Erena, N Felix ^a   Van Der Valk, Martin A ^a   Van Rijthoven, Ellen A M ^a   Roos, Ed ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; LYMPHOSARCOMA; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CELL ADHESION; CELL DIVISION; ENZYMES, IMMOBILIZED; HYALURONIC ACID; INJECTIONS, SUBCUTANEOUS; INTEGRINS; LYMPHOMA, DIFFUSE; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 0029565211     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.131.6.1849     Document Type: Article

References (43)

1. Adra, C. N., P. H. Boer, and M. W. McBurney. 1987. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene (Amst.). 60:65-74.
2. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
3. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53-66.
4. Birch, M., S. Mitchell, and I. R. Hart. 1991. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res. 51:6660-6667.
5. Camp, R. L., A. Scheynius, C. Johansson, and E. Puré. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497-507.
6. Charron, J., B. A. Malynn, E. J. Robertson, S. P. Goff, and F. W. Alt. 1990. High-frequency disruption of the N-myc gene in embryonic stem and pre-B cell lines by homologous recombination. Mol. Cell. Biol. 10:1799-1804.
7. Denning, S. M., P. T. Le, K. H. Singer, and B. F. Haynes. 1990. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144:7-15.
8. Faassen, A. E., D. L. Mooradian, R. T. Tranquillo, R. B. Dickinson, P. C. Letourneau, T. R. Oegema, and J. B. McCarthy. 1993. Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen. J. Cell Sci. 105:501-511.
9. Feldhaus, A. L., C. A. Klug, K. L. Arvin, and H. Singh. 1993. Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation. EMBO (Eur. Mol. Biol. Organ.) J. 12:2763-2772.
10. Galandrini, R., N. Albi, G. Tripodi, D. Zarcone, A. Terenzi, A. Moretta, C. E. Grossi, and A. Velardi. 1993. Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol. 150:4225-4235.
11. Galandrini, R., E. Galluzzo, N. Albi, C. E. Grossi, and A. Velardi. 1994. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J. Immunol. 153:21-31.
12. Günthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zöller, I. Haussmann, S. Matzku, A. Wenzel, H. Ponta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:13-24.
13. Guo, Y., J. Ma, J. Wang, X. Che, J. Narula, M. Bigby, M. Wu, and M. S. Sy. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54:1561-1565.
14. Hall, C. L., C. Wang, L. A. Lange, and E. A. Turley. 1994. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol. 126:575-588.
15. Hanson, K., and J. Sedivy. 1995. Analysis of biological selections for high- efficiency gene targeting. Mol. Cell. Biol. 15:45-51.
16. Huet, S., H. Groux, B. Caillou, H. Valentin, A. M. Prieur, and A. Bernard. 1989. CD44 contributes to T cell activation. J. Immunol. 143:798-801.
17. Jalkanen, S., H. Joensuu, K.-O. Söderström, and P. Klemi. 1991. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87:1835-1840.
18. Kerbel, R. S., R. R. Twiddy, and D. M. Robertson. 1978. Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int. J. Cancer. 22:583-594.
19. Laurent, T. C., and J. R. E. Fraser. 1992. Hyaluronan. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6:2397-2404.
20. Lesley, J., and R. Hyman. 1992. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. Eur. J. Immunol. 22: 2719-2723.
21. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
22. McCourt, P. A., B. Ek, N. Forsberg, and S. Gustafson. 1994. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 269:30081-30084.
23. Merzak, A., S. Koocheckpour, and G. J. Pilkington. 1994. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res. 54:3988-3992.
24. Miyake, K., K. L. Medina, S. Hayashi, S. Ono, T. Hamaoka, and P. W. Kincade. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:477-488.
25. Pals, S. T., E. Horst, G. J. Ossekoppele, C. G. Figdor, R. J. Scheper, and C. J. Meijer. 1989. Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood. 73:885-888.
26. Pierres, A., C. Lipcey, C. Mawas, and D. Olive. 1992. A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur. J. Immunol. 22:413-417.
27. Pilarski, L. M., H. Miszta, and E. A. Turley. 1993. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol. 150:4292-4302.
28. + T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 175:895-905.
29. Roossien, F. F., D. de Rijk, A. Bikker, and E. Roos. 1989. Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1- deficient mutants. J. Cell Biol. 108:1979-1985.
30. 6 integrins. Cell Adhesion Communication.1:67-82.
31. Sherman, L., J. Sleeman, P. Herrlich, and H. Ponta. 1994. Hyaluronate receptors: key players in growth, differentiation, migration, and tumor progression. Curr. Opin. Cell Biol. 6:726-733.
32. Shimizu, Y., G. A. Van Seventer, R. Siraganian, L. Wahl, and S. Shaw. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:2457-2463.
33. Sonnenberg, A., H. Daams, M. A. van der Valk, J. Hilkens, and J. Hilgers. 1986. Development of mouse mammary gland: identification of stages in differentiation of luminal and myoepithelial cells using monoclonal antibodies and polyvalent antiserum against keratin. J. Histochem. Cytochem. 34:1037-1046.
34. Sy, M. S., Y.-J. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859-866.
35. Sy, M. S., Y. J. Guo, and I. Stamenkovic. 1992. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med. 176:623-627.
36. Tan, P. H., E. B. Santos, H. C. Rossbach, and B. M. Sandmaier. 1993. Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 150:812-820.
37. te Riele, H., E. Robanus Maandag, and A. Berns. 1992. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA. 89:5128-5132.
38. te Riele, H., E. Robanus Maandag, A. Clarke, M. Hooper, and A. Berns. 1990. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature (Lond.). 348:649-651.
39. Thomas, L., H. R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:971-977.
40. Tölg, C., M. Hofmann, P. Herrlich, and H. Ponta. 1993. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1225-1229.
41. Toyama-Sorimachi, N., H. Sorimachi, Y. Tobita, F. Kitamura, Y. Hideo, K. Suzuki, and M. Miyasaka. 1995. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J. Biol. Chem. 270: 7437-7444.
42. Underhill, C. B. 1992. CD44: the hyaluronan receptor. J. Cell Sci. 103:293-298.
43. Zahalka, M. A., E. Okon, U. Gosslar, B. Holzmann, and D. Naor. 1995. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J. Immunol. 154:5345-5355.